- 2bind, GmbH, Germany
- Altermune LLC, Sandwich, Kent or CA, USA (Acquired by Cantauri Therapeutics)
- AM Biotechnologies, LLC, TX, USA
- AMS Biotechnology, Abingdon, UK
- Aptadel Therapeutics, Barcelona, Spain
- APTAGEN, LLC, PA, USA
- AptaMatrix, NY, USA
- Aptamer Group, York, UK
- Aptamer Sciences Inc, Korea
- Apta Targets Madrid, Spain
- Aptabiosciences, UK and Singapore
- AptaIT GmbH, Germany
- Apterna, UK
- Aptitude Medical Systems Inc, USA
- AptusBiotech, Spain
- Astrazeneca
- ATDBio Ltd, Southampton, UK
- AuramerBio, New Zealand
- Base Pair Biotechnologies, Inc, USA
- BBI Group, Cardiff, UK
- DSM Biotechnology, The Netherlands
- Firefly Bioworks, MA, USA
- iba GmbH Germany
- IDT DNA, Iowa, USA
- Izon Science Oxford, UK
- LC Sciences, TX, USA
- LFB Biotechnologies, France
- Nal von Minden Germany
- Neoventures, Ontario, Canada
- Novaptech
- Noxxon Pharma, AG Germany
- Ophthotech NY, USA
- OTC Biotech TX, USA
- Piculet Biosciences The Netherlands
- Pure Biologics Poland
- Ribomic Japan
- SomaLogic CO, USA
- Tobira Therapeutics CA, USA
- Tocris Bioscience Bristol, UK
- TriLink Biotechnologies CA, USA
- Veraptus, China
Credits:
Dr Maureen McKeague, Canada
Dr Sarah Shigdar, Australia
Dr Muhammad Sohail, United Kingdom